glp 1 agonist for type 1 diabetes Mechanisms of action of GLP-1RA Current Insights, Advantages and Challenges

Focus on these factors instead: Quality of the peptide (purity, proper storage, legitimate sourcing) Consistency of dosing (daily administration at similar times) Route of administration (subcutaneous is most common and effective for most uses) Adequate dosage (underdosing is more common than overdosing) Supporting recovery factors (sleep, nutrition, stress management) Ive seen people get lackluster results from improperly prepared peptides dosed perfectly, and exceptional results from high-quality BPC-157 dosed once daily

Limited human safety data

Association of TERT (rs2736098 and rs2736100) genetic variants with elevated risk of hepatocellular carcinoma: a retrospective case-control study

The project described was supported in part by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 1UL1TR002014-01

Surprisingly, a growing number of clinical studies demonstrate that these drugs (and other GLP-1 RAs) may have benefits that extend far beyond their original purpose, with their effects spanning the heart, kidneys, liver, and more